Fig. 3

Distribution of modified Rankin scale scores at 90 days after stroke. Distributions of scores on the modified Rankin scale show a favoring of the alteplase group over the placebo group. Modified Rankin scale scores range from 0 to 6 (0, no symptoms; 1, no clinically significant disability; 2, slight disability; 3, moderate disability; 4, moderately severe disability; 5, severe disability; 6, death). Numbers indicate rounded proportions. There was no significant interaction in the corresponding unconditional logistic regression model